Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-15-069845
Filing Date
2015-12-08
Accepted
2015-12-08 15:23:12
Documents
2
Group Members
BENJAMIN H. SNEDEKERDAVID BUCHENDR. JOHN H. LEAMANDR. TODD JOHNSONJAMES P. AHERNMATTHEW D. EITNERTIMOTHY S. CALLAHAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v426368_sc13da.htm SC 13D/A 110884
2 EXHIBIT 99.8 v426368_ex99-8.htm EX-99.8 24801
  Complete submission text file 0001144204-15-069845.txt   137779
Mailing Address 546 FIFTH AVENUE 5TH FLOOR NEW YORK NY 10036
Business Address 41 DOVER STREET LONDON A1 W1S 4NS 212-953-4952
LAIDLAW & COMPANY (UK) LTD. (Filed by) CIK: 0001146350 (see all company filings)

State of Incorp.: XX | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Subject) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-88207 | Film No.: 151275567
SIC: 2834 Pharmaceutical Preparations